101 related articles for article (PubMed ID: 15763798)
1. The value of human papillomavirus testing in the colposcopy clinic.
Bhaumik J; Mahadevan S; Davies AE
J Obstet Gynaecol; 2004 Oct; 24(7):817-9. PubMed ID: 15763798
[TBL] [Abstract][Full Text] [Related]
2. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
3. The impact of high risk human papillomavirus testing in an inner London colposcopy clinic.
Perrons C; Brink N; Jalal H; Watts P; Jelley R
J Med Virol; 2005 Aug; 76(4):576-82. PubMed ID: 15977240
[TBL] [Abstract][Full Text] [Related]
4. Outcome of women with index smear showing mild dyskaryosis: effects of age and evidence of HPV infection.
Winn CM; Jones H
Cytopathology; 2005 Dec; 16(6):281-9. PubMed ID: 16303041
[TBL] [Abstract][Full Text] [Related]
5. Management of women with mild and moderate cervical dyskaryosis.
Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
[TBL] [Abstract][Full Text] [Related]
6. Repeating cytology at initial colposcopy does not improve detection of high-grade abnormalities: a retrospective cohort study of 6595 women.
Rieck GC; Bhaumik J; Beer HR; Leeson SC
Gynecol Oncol; 2006 May; 101(2):228-33. PubMed ID: 16325241
[TBL] [Abstract][Full Text] [Related]
7. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
8. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
BMJ; 2004 May; 328(7451):1293. PubMed ID: 15166066
[TBL] [Abstract][Full Text] [Related]
9. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Voorhorst FJ; Bezemer PD; Verheijen RH; Meijer CJ
Lancet; 2001 Nov; 358(9295):1782-3. PubMed ID: 11734239
[TBL] [Abstract][Full Text] [Related]
10. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
[TBL] [Abstract][Full Text] [Related]
11. Detection of human papillomavirus infection in women attending a colposcopy clinic.
Selva L; Gonzalez-Bosquet E; Rodriguez-Plata MT; Esteva C; Suñol M; Muñoz-Almagro C
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):416-21. PubMed ID: 19376675
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
13. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
Howard K; Salkeld G; McCaffery K; Irwig L
Health Econ; 2008 May; 17(5):593-605. PubMed ID: 17764095
[TBL] [Abstract][Full Text] [Related]
14. DNA recovery from Hybrid Capture II samples stored in specimen transport medium with denaturing reagent, for the detection of human papillomavirus by PCR.
Rabelo-Santos SH; Levi JE; Derchain SF; Sarian LO; Zeferino LC; Messias S; Moraes DL; Campos EA; Syrjänen KJ
J Virol Methods; 2005 Jun; 126(1-2):197-201. PubMed ID: 15847937
[TBL] [Abstract][Full Text] [Related]
15. Value of normal colposcopy after an abnormal cervical smear report.
Luesley D; Downey G
J Low Genit Tract Dis; 2009 Jan; 13(1):33-7. PubMed ID: 19098604
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
17. Decision analysis for best management of mildly dyskaryotic smear.
Johnson N; Sutton J; Thornton JG; Lilford RJ; Johnson VA; Peel KR
Lancet; 1993 Jul; 342(8863):91-6. PubMed ID: 8100917
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
19. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
20. Regular audit of colposcopic biopsies from women with a mildly dyskaryotic or borderline cervical smear results in fewer cases of CINIII.
Jones MH; Jenkins D; Singer A
Cytopathology; 1996 Feb; 7(1):17-24. PubMed ID: 8833870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
